1. Hong Kong Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Miricor Enterprises Holdings Ltd

Miricor Enterprises Holdings Ltd

HHKEX:1827
0.90
HKD
+0.02
(+2.27%)
376.00MMarket Cap
Miricor Enterprises Holdings Ltd
HKEX:1827
(Hong Kong Exchange)

Recent

price

0.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
HKD
0.19
0.21
0.31
0.32
0.39
0.44
0.32
0.91
1.16
1.24
1.01
0.91
- -
Revenue per Share
0.03
0.05
- -
0.07
0.05
0.03
-0.03
0.06
-0.05
-0.03
0.03
0.03
- -
Basic EPS, GAAP
0.04
0.02
0.11
-0.06
0.02
0.13
0.05
-0.17
0.18
0.15
0.28
0.17
- -
Free Cash Flow per Basic Share
0.03
0.03
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.05
0.23
0.29
0.35
0.4
0.36
0.43
0.38
0.34
0.37
0.4
0.4
Book Value per Share
0.02
0.04
0.22
0.28
0.34
0.38
0.35
0.42
0.38
0.34
0.37
0.4
0.4
Tangible Book Value per Share
400
400
322
400
400
400
400
400
400
400
400
400
400
Basic Weighted Avg Shares
74
83
100
127
155
177
129
364
463
494
403
362
- -
Sales/Revenue/Turnover
19.54
25.92
2.42
23.67
16.54
7.78
-13.37
9.22
-4.96
-2.51
5.44
3.94
- -
Operating Margin (%)
7
6
6
7
11
30
31
60
91
93
78
66
- -
Depreciation Expense
13
18
- -
27
22
14
-13
25
-21
-13
11
11
- -
Net Income, GAAP
11.4
15.78
98.32
15.72
17.4
13.49
- -
18.65
- -
- -
53.99
23.11
- -
Effective Tax Rate (%)
18.24
22.18
0.06
20.84
14.09
7.68
-9.82
6.97
-4.43
-2.55
2.63
3.1
- -
Profit Margin (%)
-11
- -
69
91
88
90
84
-3
-13
5
51
84
84
Working Capital
- -
- -
- -
- -
- -
33
26
90
67
52
46
16
16
LT Debt
11
19
91
117
142
158
146
171
151
137
148
158
158
Total Equity
- -
117.27
0.1
24.14
14.99
6.78
- -
11.11
- -
- -
4.2
4.18
- -
Return on Invested Capital (%)
- -
124.89
0.11
25.53
16.84
8.88
- -
11.44
- -
- -
5.52
6.46
- -
Return on Capital (%)
- -
124.89
0.11
25.53
16.84
9.04
-8.33
16.02
-12.73
-8.78
7.45
7.35
- -
Return on Common Equity (%)

Capital Structure

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
43
39
35
LT Borrowings
- -
- -
- -
LT Finance Leases
46
32
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
400
Market Capitalization
468
400
376

Working Capital

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
315
323
322
Cash, Cash Equivalents & STI
182
187
205
Accounts Receivable, Net
4
3
3
Inventories
35
32
21
Total Current Liabilities
264
263
239
Payables & Accruals
- -
- -
- -
ST Debt
43
39
35
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
44.87%
2.31%
7.26%
Free Cash Flow
-10.65%
-125.72%
-39.2%
Net Income, GAAP
4,379.1%
-139.54%
6.07%
Sales/Revenue/Turnover
24.37%
37.57%
-10.11%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
494
2025
- -
- -
403
2026
- -
- -
362

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.03
2025
- -
- -
0.03
2026
- -
- -
0.03

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Miricor Enterprises Holdings Limited operates as an investment holding entity, delivering medical aesthetic and wellness beauty solutions across Hong Kong and Mainland China. The company presents a spectrum of non-surgical medical aesthetic treatments, encompassing energy-based technologies, various injection procedures, and comprehensive consultation services. It manages a portfolio of brands including CosMax medical aesthetic centers and VITAE lite-medical aesthetic facilities. Additionally, Miricor offers an array of premium skincare products, featuring items such as cleansers, toners, serums, moisturizers, eye care solutions, and sun protection products, under brands like CosMax and XOVĒ. Established to become a leading provider in its field, the firm maintains its principal operations from Central, Hong Kong.